Rajanikanth Madabushi, PhD – US Food and Drug Administration ### 1143614###Chair###Associate Director, Guidance and Scientific Policy###US Food and Drug Administration###
Chair: Rajanikanth Madabushi, PhD – US Food and Drug Administration
@@@ Akihiro Ishiguro, PhD – Pharmaceuticals and Medical Devices Agency ### 1486999###Speaker###Division Director###Pharmaceuticals and Medical Devices Agency###
Speaker: Akihiro Ishiguro, PhD – Pharmaceuticals and Medical Devices Agency
@@@ Nina Isoherranen, MSc, PhD – University of Washington ### 1487003###Speaker###Professor and Chair, Milo Gibaldi Chair###University of Washington###
Speaker: Nina Isoherranen, MSc, PhD – University of Washington
@@@ So Miyoshi, PhD – Pfizer R&D Japan ### 1487001###Speaker###Head of Clinical Pharmacology###Pfizer R&D Japan###
@@@ Kellie Schoolar Reynolds, PharmD – US Food and Drug Administration ### 1070916###Speaker###Director, Division of Infectious Disease Pharmacology###US Food and Drug Administration###
Speaker: Kellie Schoolar Reynolds, PharmD – US Food and Drug Administration
@@@ Andrew Rowland, BSc, PhD – Flinders University ### 1487005###Speaker###Associate Professor and Beat Cancer Mid-Career Research Fellow###Flinders University###
Speaker: Andrew Rowland, BSc, PhD – Flinders University
@@@ Vikram Sinha, PhD – Takeda ### 1486998###Speaker###Vice President, Global Head Quantitative Clinical Pharmacology###Takeda###
.png)
.png)